Serum leptin levels in asthmatic children treated with inhaled corticosteroid Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004
Blood glucose levels determine glucose concentration of nasal secretions Source: Eur Respir J 2002; 20: Suppl. 38, 482s Year: 2002
Effects of different serum theophylline concentrations on erythropoietin and hematocrit levels in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 422s Year: 2003
Serum and urine eosinophil markers in children and adolescents with asthma treated with once or twice daily inhaled glucocorticoids Source: Eur Respir J 2001; 18: Suppl. 33, 449s Year: 2001
Measurements of urine leptin levels in OSA patients Source: Eur Respir J 2003; 22: Suppl. 45, 90s Year: 2003
Systemic effects of nebulized salbutamol on serum potassium, glucose and CPK-MB levels in children with acute reversible reactive airway disease Source: Eur Respir J 2002; 20: Suppl. 38, 432s Year: 2002
Plasma concentrations of four corticosteroids following inhalation Source: Eur Respir J 2005; 26: Suppl. 49, 215s Year: 2005
3 month continuous positive airway pressure (CPAP) therapy decreases serum lipids, but not homocysteine and leptin concentration in patients with OSAS Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009
Glucose appears in endotracheal secretions if the blood glucose concentration is raised Source: Eur Respir J 2001; 18: Suppl. 33, 405s Year: 2001
Assessment of serum leptin level in the Egyptian asthmatic patients Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012
Changes in glucose metabolism during treatment with high doses of inhaled corticosteroids Source: Eur Respir J 2004; 24: Suppl. 48, 502s Year: 2004
Serum potassium level in patient of bronchial asthma on sequential nebulized salbutamol therapy Source: Eur Respir J 2007; 30: Suppl. 51, 621s Year: 2007
Determinants of serum leptin and adiponectin levels in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005
A preliminary study to identify correlations between blood glucose levels and cardiorespiratory observations in acute asthma patients receiving nebulised salbutamol. Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021
Blood plasma levels of ascorbic acid in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 674s Year: 2006
Effect of montelukast administration on serum IL-5 and total IgE levels in asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 579s Year: 2004
Plasma concentrations of lidocaine during bronchoscopy Source: Eur Respir J 2003; 22: Suppl. 45, 57s Year: 2003
Plasma and urinary concentrations of inhaled salmeterol in healthy and persons with asthma – Quantifying a doping limit Source: Annual Congress 2011 - Asthma management and response Year: 2011
A preliminary study to determine the effects of nebulised salbutamol on blood glucose levels during an acute asthma exacerbation. Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019
Sequential nebulized salbutamol therapy in patients of acute bronchial asthma and its effect on serum potassium level Source: Annual Congress 2009 - Treatment of airways disease Year: 2009